How to appeal a Cigna home healthcare — home nursing, home infusion, home pt/ot/slp, home aide, hospital-at-home denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Cigna-specific note: Sold its Medicaid Advantage book to HCSC in 2023. Express Scripts (PBM) is Cigna-owned. Frequent class-action litigation around mental health parity.

What Cigna's policy requires for home healthcare — home nursing, home infusion, home pt/ot/slp, home aide, hospital-at-home

Cited policy: Cigna Coverage Policy on Home Infusion + IDSA OPAT Guidelines (mirrored)

Home OPAT: stable patient; appropriate IV access (PICC/midline); drug suitable for home administration; prior 24-h hospital observation if first-dose risk; weekly MD oversight; ID consultation typical.

How Cigna denies home healthcare — home nursing, home infusion, home pt/ot/slp, home aide, hospital-at-home — and how to counter it

Where Cigna pushes back: 1) 'Inpatient until course complete'; 2) Drug not suitable for home; 3) Monitoring concerns; 4) IV access not yet placed.

Counter-arguments that hold up: Cite IDSA OPAT Guidelines (Norris CID 2018) — home OPAT cost-effective and safe for stable patients with appropriate access and monitoring. Document drug-specific safety (cefazolin, ceftriaxone, ertapenem, vancomycin, daptomycin etc. all routinely home-administered). PICC placement scheduled or in place. Document weekly MD F2F or telehealth + ID consultation + lab monitoring (CBC, BMP, vanc trough, etc.). Tice CID 2003 cost-effectiveness foundational data.

What Cigna typically denies for home healthcare — home nursing, home infusion, home pt/ot/slp, home aide, hospital-at-home

Across Cigna's commercial and Medicare books, denials cluster around a small number of patterns. For home healthcare — home nursing, home infusion, home pt/ot/slp, home aide, hospital-at-home, expect:

• Mental health parity violations
• Step therapy
• Specialty drug prior auth
• OON balance billing disputes

Treatments most often denied in this category

These are the home healthcare — home nursing, home infusion, home pt/ot/slp, home aide, hospital-at-home treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Skilled home nursing
• Home IVIG
• Home biologic infusion
• Home OPAT
• Home TPN
• Home infusion (other)

How to submit the appeal to Cigna

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Cigna cited in the denial.
3. File the appeal through Cigna's portal (members: https://my.cigna.com ; providers: https://cignaforhcp.cigna.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In CT, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Cigna's prior-authorization criteria by drug: Cigna PA criteria on ApprovalHelp.